Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 18 9 2020
pubmed: 19 9 2020
medline: 22 6 2021
Statut: ppublish

Résumé

We analyzed 1,397 HIV-1 pol sequences of antiretroviral therapy-naive patients in a total of 7 university hospitals in Bonn, Cologne, Frankfurt, Hamburg, Hannover, and Munich, Germany. Phylogenetic and network analysis elucidated numerous cases of shared drug resistance mutations among genetically linked patients; K103N was the most frequently shared mutation.

Identifiants

pubmed: 32946725
doi: 10.3201/eid2610.191506
pmc: PMC7510719
doi:

Substances chimiques

Anti-HIV Agents 0

Banques de données

ClinicalTrials.gov
['NCT02149004']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2439-2443

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI131971
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH113477
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI106039
Pays : United States

Références

JAMA. 2018 Jul 24;320(4):379-396
pubmed: 30043070
Lancet Infect Dis. 2011 May;11(5):363-71
pubmed: 21354861
J Infect Dis. 2014 Jan 15;209(2):304-13
pubmed: 24151309
PLoS One. 2014 Aug 22;9(8):e104474
pubmed: 25148412
Mol Biol Evol. 2018 Jul 1;35(7):1812-1819
pubmed: 29401317
Clin Microbiol Infect. 2019 Feb;25(2):253.e1-253.e4
pubmed: 30315957
N Engl J Med. 2002 Aug 8;347(6):385-94
pubmed: 12167680
AIDS. 2015 Oct 23;29(16):2195-200
pubmed: 26544582
Sci Rep. 2018 May 1;8(1):6799
pubmed: 29717148
Nucleic Acids Res. 2018 Jul 2;46(W1):W271-W277
pubmed: 29718426

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH